ABRAXANEPRO.COM: Keyword Density Checker

Total words: 6710 | 2-word phrases: 1699 | 3-word phrases: 2084 | 4-word phrases: 2264

PAGE INFO

Title	Try to keep the title under 60 characters (67 characters) ABRAXANE® for Injectable Suspension \| for Healthcare Professionals
Description	Try to keep the meta description between 50 - 160 characters (147 characters) Learn about dosing, efficacy, safety and patient financial information for ABRAXANE®. See full prescribing info and BOXED WARNINGS on neutropenia.
Keywords	Meta keywords are not recommended anymore (0 characters)
H1	H1 tag on the page (25 characters) DELIVER THE BRIGHT CHOICE

#	Keyword	Frequency	Density
1	the most common	33	1.58%
2	most common adverse	27	1.30%
3	common adverse reactions	27	1.30%
4	of reproductive potential	21	1.01%
5	with abraxane and	18	0.86%
6	males of reproductive	18	0.86%
7	cell lung cancer	17	0.82%
8	of patients with	16	0.77%
9	in patients with	15	0.72%
10	after the last	12	0.58%
11	reactions with a	12	0.58%
12	adenocarcinoma of the	12	0.58%
13	abraxane and for	12	0.58%
14	for at least	12	0.58%
15	months after the	12	0.58%
16	the last dose	12	0.58%
17	females of reproductive	12	0.58%
18	last dose of	12	0.58%
19	reactions resulting in	12	0.58%
20	contraception and avoid	12	0.58%
21	adverse reactions with	12	0.58%
22	adverse reactions resulting	12	0.58%
23	of abraxane in	12	0.58%
24	abraxane® is indicated	12	0.58%
25	in the abraxanegemcitabine	12	0.58%
26	dose of abraxane	12	0.58%
27	in combination with	12	0.58%
28	use of abraxane	12	0.58%
29	combination use of	12	0.58%
30	indicated for the	12	0.58%

#	Keyword	Frequency	Density
1	most common adverse reactions	27	1.19%
2	the most common adverse	24	1.06%
3	males of reproductive potential	18	0.80%
4	females of reproductive potential	12	0.53%
5	common adverse reactions resulting	12	0.53%
6	adverse reactions resulting in	12	0.53%
7	abraxane® is indicated for	12	0.53%
8	adverse reactions with a	12	0.53%
9	after the last dose	12	0.53%
10	is indicated for the	12	0.53%
11	non–small cell lung cancer	11	0.49%
12	adenocarcinoma of the pancreas	10	0.44%
13	in the abraxanegemcitabine group	9	0.40%
14	potential to use effective	9	0.40%
15	administered to a pregnant	9	0.40%
16	reproductive potential to use	9	0.40%
17	of reproductive potential to	9	0.40%
18	the last dose of	9	0.40%
19	advise females of reproductive	9	0.40%
20	to a pregnant woman	9	0.40%
21	abraxane and carboplatin vs	9	0.40%
22	when administered to a	9	0.40%
23	harm when administered to	9	0.40%
24	cause fetal harm when	9	0.40%
25	toxicity in the abraxanegemcitabine	9	0.40%
26	less than 1500 cellsmm3	9	0.40%
27	paclitaxel injection and carboplatin	9	0.40%
28	with abraxane and for	9	0.40%
29	findings in animals abraxane	9	0.40%
30	abraxane and for at	9	0.40%
31	500 cellsmm3 and platelet	9	0.40%
32	and for at least	9	0.40%
33	last dose of abraxane	9	0.40%
34	months after the last	9	0.40%
35	fetal harm when administered	9	0.40%
36	for the firstline treatment	8	0.35%
37	the firstline treatment of	8	0.35%
38	indicated for the firstline	8	0.35%
39	in combination with gemcitabine	8	0.35%
40	information including boxed warning	7	0.31%

#	URL	Whois	Check
1	https://packageinserts.bms.com/pi/pi_abraxane.pdf	Whois	bms.com
2	https://packageinserts.bms.com/ppi/ppi_abraxane.pdf	Whois	bms.com
3	https://www.abraxane.com/mpac/	Whois	abraxane.com
4	https://www.abraxane.com/mbc/	Whois	abraxane.com
5	https://www.abraxane.com/nsclc/	Whois	abraxane.com
6	https://www.bmsaccesssupport.bmscustomerconnect.com/	Whois	bmscustomerconnect.com
7	https://packageinserts.bms.com/pi/pi_abraxane.pdf	Whois	bms.com
8	https://packageinserts.bms.com/ppi/ppi_abraxane.pdf	Whois	bms.com
9	https://packageinserts.bms.com/pi/pi_abraxane.pdf	Whois	bms.com
10	https://packageinserts.bms.com/pi/pi_abraxane.pdf	Whois	bms.com
11	https://packageinserts.bms.com/pi/pi_abraxane.pdf	Whois	bms.com
12	https://packageinserts.bms.com/ppi/ppi_abraxane.pdf	Whois	bms.com
13	https://packageinserts.bms.com/pi/pi_abraxane.pdf	Whois	bms.com
14	https://packageinserts.bms.com/pi/pi_abraxane.pdf	Whois	bms.com
15	https://packageinserts.bms.com/pi/pi_abraxane.pdf	Whois	bms.com